IDEAS home Printed from https://ideas.repec.org/p/ess/wpaper/id1254.html
   My bibliography  Save this paper

Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?

Author

Listed:
  • Sergio Sismondo

Abstract

There are many reports of ghost writings and ghost management of medical journal articles. Such articles are “ghostly†because signs of their actual production are largely invisible—academic authors whose names appear at the top of ghost-managed articles give corporate research a veneer of independence and credibility.

Suggested Citation

  • Sergio Sismondo, 2007. "Ghost Management: How Much of the Medical Literature Is Shaped Behind the Scenes by the Pharmaceutical Industry?," Working Papers id:1254, eSocialSciences.
    • Handle: RePEc:ess:wpaper:id:1254
    as

    Download full text from publisher

    File URL: http://www.eSocialSciences.com/data/articles/Document117102007540.9298975.pdf
    Download Restriction: no
    ---><---

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Brun, Cédric & Demazeux, Steeves & Vittorio, Pierangelo Di & Gonon, François & Gorry, Philippe & Konsman, Jan Peter & Lung, Fanny & Lung, Yannick & Minard, Michel & Montalban, Matthieu & Rumeau, Nicol, 2015. "La construction des catégories diagnostiques de maladie mentale," Revue de la Régulation - Capitalisme, institutions, pouvoirs, Association Recherche et Régulation, vol. 17.
    2. Cédric Brun & Steeves Demazeux & Pierangelo Di Vittorio & François Gonon & Philippe Gorry & Jan Peter Konsman & Fanny Lung & Yannick Lung & Michel Minard & Matthieu Montalban & Nicole Rumeau & Andy Sm, 2015. "Construction of mental health categories [La construction des catégories diagnostiques de maladie mentale]," Post-Print hal-02195583, HAL.
    3. Ferrán Catalá-López & Gabriel Sanfélix-Gimeno & Manuel Ridao & Salvador Peiró, 2013. "When Are Statins Cost-Effective in Cardiovascular Prevention? A Systematic Review of Sponsorship Bias and Conclusions in Economic Evaluations of Statins," PLOS ONE, Public Library of Science, vol. 8(7), pages 1-1, July.
    4. Ridha Chakroun & Frédéric Teulon, 2014. "Whistleblowers in the pharmaceutical industry: tragic hero, black sheep or alter ego ?," Working Papers 2014-118, Department of Research, Ipag Business School.
    5. Tom Latten & Daan Westra & Federica Angeli & Aggie Paulus & Marleen Struss & Dirk Ruwaard, 2018. "Pharmaceutical companies and healthcare providers: Going beyond the gift – An explorative review," PLOS ONE, Public Library of Science, vol. 13(2), pages 1-15, February.
    6. Ebeling, Mary, 2011. "'Get with the Program!': Pharmaceutical marketing, symptom checklists and self-diagnosis," Social Science & Medicine, Elsevier, vol. 73(6), pages 825-832, September.
    7. Sismondo, Sergio, 2008. "How pharmaceutical industry funding affects trial outcomes: Causal structures and responses," Social Science & Medicine, Elsevier, vol. 66(9), pages 1909-1914, May.
    8. Xiaotian Chen, 2015. "Questionable University-sponsored supplements in high-impact journals," Scientometrics, Springer;Akadémiai Kiadó, vol. 105(3), pages 1985-1995, December.
    9. David Pontille & Didier Torny, 2013. "Behind the scenes of scientific articles: defining categories of fraud and regulating cases," CSI Working Papers Series 031, Centre de Sociologie de l'Innovation (CSI), Mines ParisTech.
    10. Jesse R. Catlin & Cornelia (Connie) Pechmann, 2016. "An Investigation of Consumer and Doctor Regulatory Beliefs and Regulatory Knowledge about Pharmaceutical Drug Promotions," Journal of the Association for Consumer Research, University of Chicago Press, vol. 1(3), pages 392-410.
    11. S Scott Graham & Zoltan P Majdik & Dave Clark & Molly M Kessler & Tristin Brynn Hooker, 2020. "Relationships among commercial practices and author conflicts of interest in biomedical publishing," PLOS ONE, Public Library of Science, vol. 15(7), pages 1-11, July.
    12. Kirmayer, Laurence J., 2012. "Cultural competence and evidence-based practice in mental health: Epistemic communities and the politics of pluralism," Social Science & Medicine, Elsevier, vol. 75(2), pages 249-256.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ess:wpaper:id:1254. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Padma Prakash (email available below). General contact details of provider: http://www.esocialsciences.org .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.